...
....
Pharmaceutical
Biotechnology

> See specialized channels
Medical Devices & Diagnostics
> See specialized channels
Industrial
Biotechnology
> See specialized channels


  Join us

  Follow us on Twitter   Join our LinkedIn Group   Our Blog

Biotech News App
Provides access to the latest biotech press releases ...more

Android_Logo App Store RIM_Logo_small

Media Partnership:
Want to have your RSS feed integrated on our website? Contact us
RSS Feeds RSS Feeds
JoomlaWatch Stats 1.2.9 by Matej Koval
For Editors
Sign up for press releases
For Companies
Sign up for our newsletter


All Biotech Press Releases



> NBE Therapeutics Raises CHF 20 Million in Series B Funding
11/03/16
> RedHill Biopharma Announces Proposed Public Offering of its American Depository Shares
11/02/16
> Agendia Announces the Award of a New Category 1 CPT Code from the American Medical Association for the MammaPrint® 70-Gene Breast Cancer Recurrence Assay
11/01/16
> Atomo Diagnostics Receives Grant to Develop New, Innovative HIV Self-Test Solution
10/27/16
> Agendia Expands its Business Activities in Germany
10/26/16
> BioPharmaSpec Appoints Two Senior Technical Staff from the CRO and Biosimilar Fields
10/25/16
> SOTIO and NBE Therapeutics Sign Collaboration and License Agreement for Next-Generation Antibody-Drug Conjugates
10/20/16
> Synaffix Enters into a Commercial License Agreement with ADC Therapeutics
10/20/16
> RedHill Biopharma Announces Allowance of a Patent in Japan Supporting RHB-104 for Multiple Sclerosis
10/18/16
> Agendia Appoints Three Leading Cancer Physicians to Its Medical Advisory Board
10/17/16
> Hookipa Secures ‎EUR 4.16 Million Additional Grant Support from the Austrian Research Promotion Agency (FFG) to Develop Arenavirus Vector-Based Cancer Immunotherapies
10/17/16
> RedHill Biopharma to Host Webcast Today at 8:30 am EDT Following Announcement of Progress Update on RHB-104 Phase III Crohn’s Disease Program
10/06/16
> RedHill Biopharma Provides Progress Update on RHB-104 Phase III Crohn’s Disease Program and Introduces Option for Early Stop for Success in Q2/2017
10/06/16
> Orchard Therapeutics Announces the Opening of US Operations in Foster City, California
10/06/16
> RedHill Biopharma Announces Initiation of Phase II Study with YELIVA™ in Hepatocellular Carcinoma at the Medical University of South Carolina
10/05/16
> Vector Vitale Announces New Paradigm in Medicine
10/05/16
> Karus Therapeutics Announces First Lymphoma Patients Dosed with KA2237 in Clinical Study at the MD Anderson Cancer Center
10/05/16
> Nuevolution Announces Strategic Collaboration with Amgen in Oncology and Neuroscience
10/04/16
> Argint International Voted as Top10 CRO
10/04/16
> Sartorius Stedim Biotech Launches Two Single-Use Sartocon® Loop Assemblies with Integrated Polyethersulfone (PESU) Membrane
09/30/16
> Dutch Mellon Medical Unveils Major Innovation in Surgical Suture Technology: Single-Handed Suturing Using The Switch®
09/30/16
> Quantapore Inc. Closes Series C Financing Round
09/27/16
> Shuwen Biotech's Clinical Lab Receives Accreditation from College of American Pathologists
09/23/16
> Nuevolution: Oral Presentation of Preclinical and Preliminary Toxicology Data on its BET BD1 Program at Discovery on Target 2016
09/22/16
> Orchard Therapeutics Announces Presentations from UCL/GOSH and UCLA Academic Collaborators on Clinical Data in ADA-SCID Using Ex-Vivo Lentiviral Gene Therapy at September 2016 ESID and ESGCT Congresses
09/21/16
> FierceBiotech Names Orchard Therapeutics Limited as One of Its “Fierce 15” Biotech Companies of 2016
09/21/16
> RedHill Biopharma and IntelGenx Announce RIZAPORT® Commercialization Term Sheet with Pharmatronic Co. for Korea
09/21/16
> TVM Life Science Ventures VII Announces Investment in AurKa Pharma Inc.
09/19/16
> osteomiR™: Worldwide First miRNA-based Test for Early Detection of Osteoporosis
09/19/16
> Nuevolution: Presentation of Preclinical Data on its BET BD1 Program at Discovery on Target 2016
09/16/16
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Page 3 of 46